X2S Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sinopharm Group Co Ltd

Watchlist Manager

Watchlist

Price: 1.78 EUR

Market Cap: €5.6B

S	Sinopharm Group Co Ltd F:X2S	CN
	Emperador Inc SGX:EMI	PH
G	Getlink SE SWB:TNU3	FR
D	DENTSPLY SIRONA Inc XMUN:DY2	US
F	Fairfax Financial Holdings Ltd F:FFX	CA
W	Wesco International Inc XMUN:WP7	US
	Bankinter SA F:BAKA	ES
	Moderna Inc NASDAQ:MRNA	US
D	Dohome PCL SET:DOHOME	TH
S	Sealed Air Corp F:SDA	US
N	New China Life Insurance Co Ltd XBER:NCL	CN
	TBS Holdings Inc TSE:9401	JP
	Alcon AG LSE:0A0D	CH
A	Altria Group Inc SWB:PHM7	US
W	Williams Companies Inc SWB:WMB	US

Profitability Summary

Sinopharm Group Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Declining Gross Margin

9% > 7%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

4% > 3%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

2% > 1%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

3% > 3%

Low ROE

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.